Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linotenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis
- Menendez, JA
- Colomer, R
- Lupu, R;
Medical Hypotheses (p. 337-341) - 10/1/2005
10.1016/j.mehy.2004.06.032 Ver en origen
- ISSN 03069877
Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
- Menendez, JA
- Colomer, R
- Lupu, R;
Medical Hypotheses (p. 342-349) - 1/1/2005
10.1016/j.mehy.2004.07.022 Ver en origen
- ISSN 03069877
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
- Tan AR, Im SA, Mattar A, Colomer R, Stroyakovskii D, Nowecki Z, De Laurentiis M, Pierga JY, Jung KH, Schem C, Hogea A, Badovinac Crnjevic T, Heeson S, Shivhare M, Kirschbrown WP, Restuccia E, Jackisch C, FeDeriCa study group
Lancet Oncology (p. 85-97) - 1/1/2021
10.1016/s1470-2045(20)30536-2 Ver en origen
- ISSN 14702045
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- Davies, Christina
- Pan, Hongchao
- Godwin, Jon
- Gray, Richard
- Arriagada, Rodrigo
- Raina, Vinod
- Abraham, Mirta
- Medeiros Alencar, Victor Hugo
- Badran, Atef
- Bonfill, Xavier
- Bradbury, Joan
- Clarke, Michael
- Collins, Rory
- Davis, Susan R
- Delmestri, Antonella
- Forbes, John F
- Haddad, Peiman
- Hou, Ming-Feng
- Inbar, Moshe
- Khaled, Hussein
- Kielanowska, Joanna
- Kwan, Wing-Hong
- Mathew, Beela S
- Mittra, Indraneel
- Muller, Bettina
- Nicolucci, Antonio
- Peralta, Octavio
- Pernas, Fany
- Petruzelka, Lubos
- Pienkowski, Tadeusz
- Radhika, Ramachandran
- Rajan, Balakrishnan
- Rubach, Maryna T
- Tort, Sera
- Urrutia, Gerard
- Valentini, Miriam
- Wang, Yaochen
- Peto, Richard
Lancet (p. 805-816) - 9/3/2013
10.1016/s0140-6736(12)61963-1 Ver en origen
- ISSN 01406736
Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with bone metastases (BOMET-QoL)
- Adrover E
- Allepuz J
- Sureda A
- Domine M
- Barnadas A
- Constela M
- Lluch A
- Ruiz M
- Piera J
- Mayordomo JI
- Morales A
- Muñoz M
- Alcover J
- Colomer R
- Llombart A
- Massutti B
- Carballido J
- Garrido P
- García R
- Badia X
- Lizan L
- Gilabert M
Journal Of Outcomes Research (p. 15-27) - 1/1/2005
- ISSN 1369698x
- iMarina
Predictors of unknown cancer in patients with ischemic stroke
- Quintas, S.
- Rogado, J.
- Gullón, P.
- Pacheco-Barcia, V.
- Dotor García-Soto, J.
- Reig-Roselló, G.
- Mondéjar, R.
- Colomer, R.
- Vivancos, J.
Journal Of Neuro-Oncology (p. 551-557) - 1/5/2018
Editor: Springer New York LLC
10.1007/s11060-017-2741-0 Ver en origen
- ISSN 0167594X
- ISSN/ISBN 1573-7373
Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia
- Sureda A., Isla D., Cózar J.M., Ruiz M., Domine M., Margelí M., Adrover E., Ramos M., Pastor M., Martín A., Llombart A., Massuti B., Muñoz M., Barnadas A., Fernández J., Colomer R., Allepuz C., Gilabert M., Badia X.
Journal Of Medical Economics (p. 27-39) - 1/1/2007
10.3111/200710027039 Ver en origen
- ISSN 1941837X
Creatine transporter deficiency in two adult patients with static encephalopathy
- Sempere A., Fons C., Arias A., Rodríguez-Pombo P., Colomer R., Merinero B., Alcaide P., Capdevila A., Ribes A., Artuch R., Campistol J.
Journal Of Inherited Metabolic Disease (p. S91-6) - 1/1/2009
10.1007/s10545-009-1083-2 Ver en origen
- ISSN 01418955
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner
- Manes, Santos
- Mira, Emilia
- Colomer, Ramon
- Montero, Sagrario
- Real, Luis M
- Gomez-Mouton, Concepcion
- Jimenez-Baranda, Sonia
- Garzon, Alfredo
- Lacalle, Rosa Ana
- Harshman, Keith
- Ruiz, Agustin
- Martinez-A, Carlos
Journal Of Experimental Medicine (p. 1381-1389) - 3/11/2003
10.1084/jem.20030580 Ver en origen
- ISSN 00221007
Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with bone metastases (BOMET-QoL)
- E Adrover
- J Allepuz
- A Sureda
- M Domine
- A Barnadas
- M Constela
- A Lluch
- M Ruiz
- J Piera
- JI Mayordomo
Journal Of Drug Assessment (p. 209-209) - 1/1/2005
- ISSN 13699474
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Tratado de oncología
- Hernán Cortés-Funes
- Ramón Colomer Bosch
- Emilio Alba Conejo
1/1/2009
- ISBN 9788492620166
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Tratamiento hormonal del cáncer
- Ramón Colomer Bosch
- M L Amador
- J González Cortijo
- MV Tornamira
Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with …
- M Marangolo
- I Lang
- C Beato
- R Colomer
- L Ukarma
(p. 388-388) - 1/1/2005
- iMarina
ESTIMATED COSTS OF LOCOREGIONAL AND METASTATIC RECURRENCES IN PATIENTS WITH HER2+BREAST CANCER IN SPAIN
- Albanell, J.
- Ciruelos, E.
- De la Haba, J.
- Martin, M.
- Munoz-Molina, B.
- De Salas-Cansado, M.
- Colomer, R.;
Value In Health (p. A729-A729) - 1/1/2016
10.1016/j.jval.2016.09.2190 Ver en origen
- ISSN 10983015
PERFORMANCE AND ADEQUACY OF PATIENT-PERSPECTIVE CRITERIA IN THE ASSESSMENT OF TEST-RETEST RELIABILITY: THE CASE OF THE PERFORM QUESTIONNAIRE
- Baro, E
- Rodriguez, C
- Gascon, P
- Garcia-Mata, J
- Colomer, R
- Cassinello, J
- Carulla, J
- Valentin, V
- Gasquet, J A
Value In Health (p. A486-A486) - 1/1/2008
10.1016/s1098-3015(10)66620-x Ver en origen
- ISSN 10983015
Sensitivity to change of the perform questionnaire (PQ) in cancer patients reporting improvement or deterioration of their cancer-related fatigue
- Baro, E
- Cassinello, J
- Caruiia, J
- Valentin, V
- C, Rodriguez
- Gascon, P
- J, Garcia-Mata
- Colomer, R
- Gasquet, J A
Value In Health (p. A343-A344) - 1/1/2007
10.1016/s1098-3015(10)65226-6 Ver en origen
- ISSN 10983015
Using psychometric and clinimetric techniques to select items for use in a new instrument to measure cancer-related fatigue
- Baro, E
- Carulla, J
- Valentin, V
- Rodriguez, C
- Gascon, P
- Garcia-Mata, J
- Colomer, R
- Cassinello, J
- Herdman, M
- Gasquet, J A
- Sanchez, J
Value In Health (p. A203-A203) - 1/1/2006
10.1016/s1098-3015(10)63204-4 Ver en origen
- ISSN 10983015
CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN
- Ciruelos, E.
- Alba, E.
- Lopez, R.
- Lluch, A.
- Martin, M.
- Arroyo, I
- Navarro, B.
- Carcedo, D.
- Colomer, R.
- Albanell, J.;
Value In Health (p. S18-S18) - 1/1/2018
10.1016/j.jval.2018.09.102 Ver en origen
- ISSN 10983015
COST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAINCO ST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAIN
- Colomer, R.
- Ciruelos, E.
- De la Haba, J.
- Martin, M.
- De Salas-Cansado, M.
- Munoz-Molina, B.
- Albanell, J.;
Value In Health (p. A740-A740) - 1/1/2016
10.1016/j.jval.2016.09.2249 Ver en origen
- ISSN 10983015
TREATMENT RATES IN PATIENTS WITH HER2+METASTATIC BREAST CANCER AND THE FACTORS INFLUENCING TREATMENT DECISION
- Colomer, R.
- Hall, P.
- Szkultecka-Debek, M.
- Bondi, R.
- Flinois, A.
- Auziere, S.
- Le Cleach, J.;
Value In Health (p. A764-A765) - 1/1/2016
10.1016/j.jval.2016.09.2386 Ver en origen
- ISSN 10983015
RESPONSE TO TARGETED THERAPY AND HEALTHCARE RESOURCE UTILIZATION (HRU): A EUROPEAN RETROSPECTIVE CHART REVIEW STUDY IN PATIENTS WITH HER2+METASTATIC BREAST CANCER
- Colomer, R.
- Hall, P.
- Szkultecka-Debek, M.
- Bondi, R.
- Flinois, A.
- Le Cleach, J.;
Value In Health (p. A742-A742) - 1/1/2016
10.1016/j.jval.2016.09.2260 Ver en origen
- ISSN 10983015
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas
- Rebeca Mondéjar Solís (Director)
- Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia
28/1/2021
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id